A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 9/28 (2006.01) A61K 31/4015 (2006.01)
Patent
CA 2696977
The present invention relates to a pharmaceutical formulation of solid dosage forms comprising a therapeutically effective amount of a pyrrolidone anticonvulsant agent, and in particular Levetiracetam or a pharmaceutical acceptable salt or derivative thereof, in combination with an effective diluent, such as Dibasic Calcium Phosphate, and additional pharmaceutical excipients, and a process for the preparation thereof by wet granulation.
La présente invention concerne une formulation pharmaceutique de formes dosifiées solides comprenant une quantité thérapeutiquement efficace d'un agent anticonvulsif à base de pyrrolidone, et en particulier du Lévétiracétam ou un dérivé ou un sel pharmaceutiquement acceptable de celui-ci, en combinaison avec un diluant efficace, tel que le phosphate de calcium dibasique, et des excipients pharmaceutiques supplémentaires. La présente invention concerne également un procédé de préparation de celui-ci par granulation humide.
Bikiaris Dimitrios
Karavas Evangelos
Koutri Ioanna
Koutris Efthimios
Samara Vicky
Dimock Stratton Llp
Pharmathen S.a.
LandOfFree
Improved pharmaceutical composition containing a pyrrolidone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Improved pharmaceutical composition containing a pyrrolidone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved pharmaceutical composition containing a pyrrolidone... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1503408